DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
El-Far M, Salah N, Essam A. et al.
Silymarin nanoformulation as potential anticancer agent in experimental Ehrlich
ascites carcinoma-bearing animals.
Nanomedicine 2018;
13: 1865-1888
DOI: 10.2217/nnm-2017-0394.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.